# Foghorn Therapeutics Inc.: Form 10-Q/A for the period ended Mar 31, 2022

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 10-Q/A
- Filed: 2022-07-28
- Accepted by EDGAR: Jul 28, 2022, 07:20 ET
- Period: 2022-03-31
- Accession: 0001628280-22-019639
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828022019639/fhtx-20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828022019639/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828022019639/fhtx-20220331.htm

Filed Jul 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-019639. Last ingested by Listed: Nov 9, 2026, 17:27 ET. No prices; not investment advice.
